| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 632.10M | 619.20M | 671.20M | 719.37M | 589.26M |
| Gross Profit | 209.70M | 391.50M | 220.10M | 250.82M | 199.49M |
| EBITDA | 93.80M | 84.20M | 84.30M | 90.08M | 103.89M |
| Net Income | 14.40M | 31.00M | 18.60M | 26.80M | 54.81M |
Balance Sheet | |||||
| Total Assets | 1.04B | 1.08B | 1.11B | 1.21B | 595.97M |
| Cash, Cash Equivalents and Short-Term Investments | 4.90M | 18.90M | 34.50M | 56.26M | 41.21M |
| Total Debt | 181.90M | 188.20M | 252.10M | 292.87M | 82.33M |
| Total Liabilities | 385.70M | 414.80M | 472.80M | 547.80M | 251.66M |
| Stockholders Equity | 655.70M | 661.30M | 641.30M | 660.29M | 343.33M |
Cash Flow | |||||
| Free Cash Flow | 22.90M | 67.60M | 56.90M | 55.19M | 43.62M |
| Operating Cash Flow | 38.90M | 76.80M | 77.70M | 85.34M | 65.54M |
| Investing Cash Flow | -15.70M | -9.80M | -18.20M | -114.94M | -7.03M |
| Financing Cash Flow | -37.00M | -82.70M | -81.10M | 44.35M | -120.95M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | £1.03B | 13.59 | 7.14% | 4.47% | 7.83% | -7.40% | |
62 Neutral | £324.26M | 10.08 | 7.33% | 2.13% | 15.99% | 96.05% | |
62 Neutral | £64.82M | 21.11 | 3.91% | 5.35% | -0.29% | -33.41% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | £1.28B | 17.54 | 10.11% | ― | 32.27% | ― | |
53 Neutral | £340.02M | 11.50 | 2.91% | 4.18% | 1.31% | 10.19% | |
48 Neutral | £399.24M | 179.13 | 0.79% | 2.39% | 5.58% | 66.49% |